充值vip 上传试卷赚钱
快速导航
学历类
职业资格
公务员
医卫类
建筑工程
外语类
外贸类
计算机类
财会类
技能鉴定
特种作业
安全生产
医疗药物
交通相关
科技类
食品类
服务行业
健康护理
其他类
当前位置：考试网  > 试卷库  > 技能鉴定  > 其他类  > 锉刀的齿纹排列形式有哪两种个用于什么场合
试题预览

锉刀的齿纹排列形式有哪两种个用于什么场合

查看答案
收藏
纠错
正确答案：

一种是锉齿按一个方向排列，称为单纹锉，主要适用于锉削铝、铜等软材料；另一种是锉齿按两个方向排列，称为双纹锉，主要适用于锉削硬钢、铸铁的硬材料。

答案解析：

暂无解析

上一题 下一题
你可能感兴趣的试题

电动的工具、机具应 ( ) 或( ) 良好。

查看答案

油气田的探明储量（ ）

查看答案

销售员在销售中要自信、自强表现出积极向上的精神面貌。

查看答案

假设某汽车制造厂去年生产一辆君威 3.0 所需时间为半年，今年生产同一型号车辆所需实际缩减为 5 个月，由于劳动时间减少造成的该种车辆成本降低属于经济性功能贬值。

查看答案

一个工作负责人只能同时发给（）工作票

查看答案
热门试题 更多>
数据库系统处理死锁一般采用哪两类方法?简述每类方法的基本原理
试题分类： 计算机四级
练习次数：0次
Many people think that arts (painting and music) do not directly improve people's life, so the government should spend money on other important areas. Do you agree or disagree?
试题分类： 写作
练习次数：0次
SAS employs a full-time ergonomics specialist to select office furniture that will reduce physical stress and strain.
试题分类： 初级(口语)
练习次数：0次
Nutritious refreshment
试题分类： 初级(口语)
练习次数：0次
我国通过国际铁路联运可运达的国家有哪些?
试题分类： 理论与实务
练习次数：0次
世界原油出产可定满足不了全球需求。
试题分类： 口语
练习次数：0次
1.The failure of a high-profile cholesterol drug has thrown a spotlight on the complicated machinery that regulates cholesterol levels.But many researchers remain confident that drugs to boost levels of 'good' cholesterol are still one of the most promising means to combat spiralling heart disease. 2.Drug company Pfizer announced on 2 December that it was cancelling all clinical trials of torcetrapib，a drug designed to raise heart-protective high-density lipoproteins (HDLs).In a trial of 15000 patients，a safety board found that more people died or suffered cardiovascular problems after taking the drug plus a cholesterol-lowering statin than those in a control group who took the statin alone. 3.The news came as a kick in the teeth to many cardiologists because earlier tests in animals and people suggested it would lower rates of cardiovascular disease."There have been no red flags to my knowledge," says John Chapman，a specialist in lipoproteins and atherosclerosis at the National Institute for Health and Medical Research (INSERM) in Paris who has also studied torcetrapib."This cancellation came as a complete shock." 4.Torcetrapib is one of the most advanced of a new breed of drugs designed to raise levels of HDLs，which ferry cholesterol out of artery-clogging plaques to the liver for removal from the body.Specifically，torcetrapib blocks a protein called cholesterol ester transfer protein (CETP)，which normally transfers the cholesterol from high-density lipoproteins to low density，plaque-promoting ones.Statins，in contrast，mainly work by lowering the 'bad' low-density lipoproteins. Under pressure 5.Researchers are now trying to work out why and how the drug backfired，something that will not become clear until the clinical details are released by Pfizer.One hint lies in evidence from earlier trials that it slightly raises blood pressure in some patients.It was thought that this mild problem would be offset by the heart benefits of the drug.But it is possible that it actually proved fatal in some patients who already suffered high blood pressure.If blood pressure is the explanation，it would actually be good news for drug developers because it suggests that the problems are specific to this compound.Other prototype drugs that are being developed to block CETP work in a slightly different way and might not suffer the same downfall. 6.But it is also possible that the whole idea of blocking CETP is flawed，says Moti Kashyap，who directs atherosclerosis research at the VA Medical Center in Long Beach，California.When HDLs excrete cholesterol in the liver，they actually rely on LDLs for part of this process.So inhibiting CETP，which prevents the transfer of cholesterol from HDL to LDL，might actually cause an abnormal and irreversible accumulation of cholesterol in the body."You're blocking a physiologic mechanism to eliminate cholesterol and effectively constipating the pathway," says Kashyap.Going up 7.Most researchers remain confident that elevating high density lipoproteins levels by one means or another is one of the best routes for helping heart disease patients.But HDLs are complex and not entirely understood.One approved drug，called niacin，is known to both raise HDL and reduce cardiovascular risk but also causes an unpleasant sensation of heat and tingling.Researchers are exploring whether they can bypass this side effect and whether niacin can lower disease risk more than statins alone.Scientists are also working on several other means to bump up high-density lipoproteins by，for example，introducing synthetic HDLs."The only thing we know is dead in the water is torcetrapib，not the whole idea of raising HDL," says Michael Miller，director of preventive cardiology at the University of Maryland Medical Center，Baltimore. Questions 7-13 Match torcetrapib，HDLs，statin and CETP with their functions (Questions 8-13)..Write the correct letter A，B，C or D in boxes 8-13 on your answer sheet.NB You may use any letter more than once. 7.It has been administered to over 10,000 subjects in a clinical trial. 8.It could help rid human body of cholesterol. 9.Researchers are yet to find more about it. 10.It was used to reduce the level of cholesterol. 11.According to Kashyap，it might lead to unwanted result if it's blocked. 12.It produced contradictory results in different trials. 13.It could inhibit LDLs.List of choices A.TorcetrapicB.HDLSC.StatinD.CETP
试题分类： 阅读
练习次数：3次
Not really. It is shrewd business operations.
试题分类： 初级(口语)
练习次数：0次
Importance of Education
试题分类： 写作
练习次数：0次
The terms of payment we wish to adopt are confirmed and irrevocable letter of credit.
试题分类： 口语
练习次数：1次
相关题库 更多>
特种作业 安全生产 医疗药物 交通相关 科技类 食品类 服务行业 健康护理 其他类
新手指南
会员服务
服务支持
扫一扫，手机做题